Pediatric Community-Acquired Bone and Joint Staphylococcus Aureus Infections In Europe Severe Infections are Associated to Panton-Valentine Leucocidin Presence
Por:
Gijón M, Bellusci M, Petraitiene B, Noguera-Julian A, Glikman D, Saavedra-Lozano J, Neth O, Daskalaki M, Zilinskaite V, Kaiser-Labusch P, Prieto L and Rojo P
Publicada:
1 jun 2020
Ahead of Print:
20 mar 2020
Resumen:
To analyze host and pathogen factors related to disease severity of community-acquired bone and joint infections in children, a cohort of pediatric patients was prospectively recruited from 13 centers in 7 European countries. A total of 85 children were included, 11 (13%) had a severe infection. Panton-Valentine leukocidin-positive isolates were 17%, and 6% of the isolates were methicillin-resistant Staphylococcus aureus. Multivariate analysis identified Panton-Valentine leukocidin presence (adjusted odds ratio, 12.6; P = 0.01) as the only factor independently associated with severe outcome, regardless of methicillin resistance.
Filiaciones:
Gijón M:
From the Pediatric Infectious Diseases Department. Hospital 12 de Octubre, Madrid, Spain
Bellusci M:
From the Pediatric Infectious Diseases Department. Hospital 12 de Octubre, Madrid, Spain
Petraitiene B:
Department of Pediatrics, Hospital of Lithuanian University of Health Sciences Kauno klinikos, Lithuanian University of Health Science, Kaunas, Lithuania
Noguera-Julian A:
Malalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria, Unitat d'Infeccions, Servei de Pediatria, Institut de Recerca Pediàtrica Hospital SantJoan de Déu, Barcelona, Spain
Departament de Pediatria, Universitat de Barcelona, Barcelona, Spain
CIBER de Epidemiología y Salud Pública, CIBERESP, Madrid, Spain. Red de Investigación Translacional en Infectología Pediátrica, RITIP, Madrid, Spain
Glikman D:
The Azrieli Faculty of Medicine in The Galilee, Bar-Ilan University, Safed, Israel
Saavedra-Lozano J:
Pediatric Infectious Disease Unit. Gregorio Marañón Hospital. Complutense University. Madrid. Spain
Neth O:
Paediatric Infectious diseases, Hospital Universitario Virgen del Rocío, Sevilla, Spain
Daskalaki M:
Clinical Microbiology. Penteli Children's Hospital Athens, Greece
Zilinskaite V:
Vilnius University Faculty of Medicine Institute of Clinical Medicine Clinic of Children's Diseases, Lithuania
Kaiser-Labusch P:
Prof. Hess Childrens Hospital, Bremen, Germany
Prieto L:
Pediatric Infectious diseases, Hospital de Getafe, Getafe, Spain
Rojo P:
From the Pediatric Infectious Diseases Department. Hospital 12 de Octubre, Madrid, Spain
Universidad Complutense de Madrid
Bronze
|